Quanterix Corp (QTRX) - Product Pipeline Analysis, 2019 Update

Quanterix Corp (QTRX) - Product Pipeline Analysis, 2019 Update

Summary

Quanterix Corp (Quanterix) is a life sciences company that develops and markets ultra-sensitive digital immunoassay platform that improves precision health for life sciences research and diagnostics. It develops platform based on its proprietary digital single molecule array, Simoa detection technology that allows the detection of proteins and nucleic acids in biological samples. Quanterix’s kits include components required to run tests, such as capture and detector reagents, beads, enzyme reagents and enzyme substrates. Its consumables include Simoa disks, cuvettes and disposable tips. Its technology is used for research applications in various therapeutic areas, including neurology, cardiology, oncology, inflammation and infectious diseases. The company’s Simoa technology serves life science research, diagnostics and precision health screening markets. It also provides contract research services. Quanterix is headquartered in Lexington, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Quanterix Corp
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Quanterix Corp Company Overview
Quanterix Corp Company Snapshot
Quanterix Corp Pipeline Products and Ongoing Clinical Trials Overview
Quanterix Corp – Pipeline Analysis Overview
Quanterix Corp - Key Facts
Quanterix Corp - Major Products and Services
Quanterix Corp Pipeline Products by Development Stage
Quanterix Corp Pipeline Products Overview
AccuPSA Test
AccuPSA Test Product Overview
Antigen Detection Assay - Tuberculosis
Antigen Detection Assay - Tuberculosis Product Overview
Diagnostic Blood Test - Huntington’s Disease
Diagnostic Blood Test - Huntington’s Disease Product Overview
Digital ELISA - Crohn’s Disease
Digital ELISA - Crohn’s Disease Product Overview
Digital ELISA Assay - C. Difficile
Digital ELISA Assay - C. Difficile Product Overview
NeuroFilament Light Assay - Alzheimer’s Disease
NeuroFilament Light Assay - Alzheimer’s Disease Product Overview
POC Device - Neurological Injuries
POC Device - Neurological Injuries Product Overview
Simoa 3.0
Simoa 3.0 Product Overview
Simoa 4.0
Simoa 4.0 Product Overview
Simoa 5.0
Simoa 5.0 Product Overview
SiMoA HD-1 Analyzer - Botulinum Toxin Assay
SiMoA HD-1 Analyzer - Botulinum Toxin Assay Product Overview
Simoa HD-1 Analyzer - Lung Cancer
Simoa HD-1 Analyzer - Lung Cancer Product Overview
Simoa HD-1 Analyzer - Pancreatic Cancer
Simoa HD-1 Analyzer - Pancreatic Cancer Product Overview
SiMoA HD-1 Analyzer - Prostate Cancer Assay
SiMoA HD-1 Analyzer - Prostate Cancer Assay Product Overview
Quanterix Corp - Key Competitors
Quanterix Corp - Key Employees
Quanterix Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Quanterix Corp, Recent Developments
Nov 06, 2019: Quanterix releases operating results for third quarter 2019
Oct 03, 2019: Quanterix announces recipients of annual accelerator grant program
Sep 16, 2019: Quanterix Serum Nf-L Assay powers key trial and study results presented at ECTRIMS 2019
Sep 11, 2019: Quanterix Simoa technology powers Multiple Sclerosis research with more than 50 presentations at ECTRIMS 2019
Aug 06, 2019: Quanterix releases operating results for second quarter 2019
Jul 26, 2019: Sarah Hlavinka elected to Quanterix board of directors
Jun 04, 2019: Quanterix raises $49.7 million and announces introduction of latest model Simoa HD-X Analyzer at BIO 2019 International Convention
May 29, 2019: Quanterix expands headquarters to new, state-of-the-art facility in Billerica, Mass. as demand continues to grow for its disruptive Simoa platforms
May 09, 2019: Quanterix releases operating results for first quarter 2019
May 06, 2019: Quanterix’ Simoa Technology powers more than 85 percent of neurofilament light biomarker research to be unveiled at American Academy of Neurology Annual Meeting
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Quanterix Corp Pipeline Products and Ongoing Clinical Trials Overview
Quanterix Corp Pipeline Products by Equipment Type
Quanterix Corp Pipeline Products by Indication
Quanterix Corp, Key Facts
Quanterix Corp, Major Products and Services
Quanterix Corp Number of Pipeline Products by Development Stage
Quanterix Corp Pipeline Products Summary by Development Stage
AccuPSA Test - Product Status
AccuPSA Test - Product Description
Antigen Detection Assay - Tuberculosis - Product Status
Antigen Detection Assay - Tuberculosis - Product Description
Diagnostic Blood Test - Huntington’s Disease - Product Status
Diagnostic Blood Test - Huntington’s Disease - Product Description
Digital ELISA - Crohn’s Disease - Product Status
Digital ELISA - Crohn’s Disease - Product Description
Digital ELISA Assay - C. Difficile - Product Status
Digital ELISA Assay - C. Difficile - Product Description
NeuroFilament Light Assay - Alzheimer’s Disease - Product Status
NeuroFilament Light Assay - Alzheimer’s Disease - Product Description
POC Device - Neurological Injuries - Product Status
POC Device - Neurological Injuries - Product Description
Simoa 3.0 - Product Status
Simoa 3.0 - Product Description
Simoa 4.0 - Product Status
Simoa 4.0 - Product Description
Simoa 5.0 - Product Status
Simoa 5.0 - Product Description
SiMoA HD-1 Analyzer - Botulinum Toxin Assay - Product Status
SiMoA HD-1 Analyzer - Botulinum Toxin Assay - Product Description
Simoa HD-1 Analyzer - Lung Cancer - Product Status
Simoa HD-1 Analyzer - Lung Cancer - Product Description
Simoa HD-1 Analyzer - Pancreatic Cancer - Product Status
Simoa HD-1 Analyzer - Pancreatic Cancer - Product Description
SiMoA HD-1 Analyzer - Prostate Cancer Assay - Product Status
SiMoA HD-1 Analyzer - Prostate Cancer Assay - Product Description
Quanterix Corp, Key Employees
Quanterix Corp, Subsidiaries
Glossary
List of Figures
Quanterix Corp Pipeline Products by Equipment Type
Quanterix Corp Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook